Literature DB >> 27645818

Adulterants in Urine Drug Testing.

S Fu1.   

Abstract

Urine drug testing plays an important role in monitoring licit and illicit drug use for both medico-legal and clinical purposes. One of the major challenges of urine drug testing is adulteration, a practice involving manipulation of a urine specimen with chemical adulterants to produce a false negative test result. This problem is compounded by the number of easily obtained chemicals that can effectively adulterate a urine specimen. Common adulterants include some household chemicals such as hypochlorite bleach, laundry detergent, table salt, and toilet bowl cleaner and many commercial products such as UrinAid (glutaraldehyde), Stealth® (containing peroxidase and peroxide), Urine Luck (pyridinium chlorochromate, PCC), and Klear® (potassium nitrite) available through the Internet. These adulterants can invalidate a screening test result, a confirmatory test result, or both. To counteract urine adulteration, drug testing laboratories have developed a number of analytical methods to detect adulterants in a urine specimen. While these methods are useful in detecting urine adulteration when such activities are suspected, they do not reveal what types of drugs are being concealed. This is particularly the case when oxidizing urine adulterants are involved as these oxidants are capable of destroying drugs and their metabolites in urine, rendering the drug analytes undetectable by any testing technology. One promising approach to address this current limitation has been the use of unique oxidation products formed from reaction of drug analytes with oxidizing adulterants as markers for monitoring drug misuse and urine adulteration. This novel approach will ultimately improve the effectiveness of the current urine drug testing programs.
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adulterant; Amphetamine; Cannabis; Cocaine; Drugs of abuse; Opiate; Urine adulteration; Urine drug testing; Urine manipulation

Mesh:

Substances:

Year:  2016        PMID: 27645818     DOI: 10.1016/bs.acc.2016.05.003

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  5 in total

1.  OpiTrack: A Wearable-based Clinical Opioid Use Tracker with Temporal Convolutional Attention Networks.

Authors:  Bhanu Teja Gullapalli; Stephanie Carreiro; Brittany P Chapman; Deepak Ganesan; Jan Sjoquist; Tauhidur Rahman
Journal:  Proc ACM Interact Mob Wearable Ubiquitous Technol       Date:  2021-09-14

Review 2.  Screening Pregnant Women and Their Neonates for Illicit Drug Use: Consideration of the Integrated Technical, Medical, Ethical, Legal, and Social Issues.

Authors:  Hayley R Price; Abby C Collier; Tricia E Wright
Journal:  Front Pharmacol       Date:  2018-08-28       Impact factor: 5.810

3.  Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?

Authors:  Benedikt Bernd Claus; Michael Specka; Heath McAnally; Norbert Scherbaum; Fabrizio Schifano; Udo Bonnet
Journal:  Front Psychiatry       Date:  2020-12-03       Impact factor: 4.157

4.  Unforeseen uses of oral contraceptive pills: Exploratory study in Jordanian community pharmacies.

Authors:  Muna Barakat; Raja'a Al-Qudah; Amal Akour; Najem Al-Qudah; Yahya H Dallal Bashi
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.240

5.  Knowledge and beliefs about the use/abuse of oral contraceptive pills among males: A mixed-method explanatory sequential study in community pharmacy settings.

Authors:  Muna Barakat; Raja'a Al-Qudah; Amal Akour; Mona Abu-Asal; Samar Thiab; Yahya H Dallal Bashi
Journal:  PLoS One       Date:  2021-05-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.